North East and North Cumbria
ICS Formulary
Home
About
Admin
netFormulary
Chapters
Medicines A-Z
News
Mobile
Reports
Feedback
Search
Recent Updates - Updated items
All Formulary Amendments
Records 1 to 13 of 13
Details
UPD
Published from Draft Mode
18/01/2024 11:23:36
(LoweryM )
LDL
Link Added : NICE TA921: Ruxolitinib for treating polycythaemia vera : https://www.nice.org.uk/guidance/ta921
12/01/2024 13:46:10
(DavidS )
UPD
sitematrix Changed from 0 to
12/01/2024 13:45:41
(DavidS )
UPD
isDraft Changed from N to Y
12/01/2024 13:45:41
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of disease-related splenomegaly or symptoms in adults with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemiaa myelofibrosis, only
12/01/2024 13:45:41
(DavidS )
UPD
Ruxolitinib NICE TA921 and NHSE SSC 2564
12/01/2024 13:45:41
(DavidS )
UPD
sitematrix Changed from 0 to
20/11/2023 12:45:07
(DavidS )
UPD
FurtherInformation Changed from
Approved for the treatment of disease-related splenomegaly or symptoms in adults with primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemiaa myelofibrosis, on
20/11/2023 12:45:06
(DavidS )
UPD
Ruxolitinib updated formatting
20/11/2023 12:45:06
(DavidS )
UPD
Ruxolitinib changed to protein kinase inhibitor
09/05/2018 11:33:39
(LoweryM )
UPD
Ruxolitinib b
01/02/2017 14:47:18
(DavidS )
UPD
Ruxolitinib b
23/01/2017 14:08:48
(WhitehallJ )
UPD
Ruxolitinib b
23/01/2017 14:08:05
(WhitehallJ )